{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:16:32Z","timestamp":1648682192018},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.path.2010.03.003","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T10:03:39Z","timestamp":1298455419000},"page":"461-478","source":"Crossref","is-referenced-by-count":1,"title":["Hereditary Carcinomas of the Ovary, Fallopian Tube, and Peritoneum"],"prefix":"10.1016","volume":"4","author":[{"given":"Patricia A.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.path.2010.03.003_bib1","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.path.2010.03.003_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2000.6095","article-title":"A genetic epidemiological study of carcinoma of the fallopian tube","volume":"80","author":"Aziz","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/gyno.2002.6853","article-title":"Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women","volume":"88","author":"Menczer","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2010.03.003_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molonc.2009.02.004","article-title":"Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management","volume":"3","author":"Lynch","year":"2009","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1016\/j.path.2010.03.003_bib5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"20","key":"10.1016\/j.path.2010.03.003_bib6","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2001.19.20.4074","article-title":"MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families","volume":"19","author":"Vasen","year":"2001","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.path.2010.03.003_bib7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations","volume":"31","author":"Werness","year":"2000","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.path.2010.03.003_bib8","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.path.2010.03.003_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Histopathologic features of genetically determined ovarian cancer","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.path.2010.03.003_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W","article-title":"Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up","volume":"82","author":"Shimizu","year":"1998","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","article-title":"Histopathologic grading of ovarian carcinoma: a review and proposal","volume":"19","author":"Silverberg","year":"2000","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.path.2010.03.003_bib12","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"27","author":"Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.path.2010.03.003_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jcp.52.5.372","article-title":"Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations","volume":"52","author":"Zweemer","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.path.2010.03.003_bib14","first-page":"3193","article-title":"Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers","volume":"58","author":"Rhei","year":"1998","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.path.2010.03.003_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance","volume":"18","author":"Salani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.path.2010.03.003_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jcp.2007.053793","article-title":"An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma","volume":"61","author":"Miller","year":"2008","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2010.03.003_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2008.191","article-title":"Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss","volume":"22","author":"Clarke","year":"2009","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.path.2010.03.003_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/PAS.0b013e31819e986a","article-title":"Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2007.11.6905","article-title":"Effect of BRCA1\/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer","volume":"26","author":"Chetrit","year":"2008","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.path.2010.03.003_bib20","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1200\/JCO.2008.16.1703","article-title":"\u201cBRCAness\u201d syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations","volume":"26","author":"Tan","year":"2008","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.path.2010.03.003_bib21","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-07-1083","article-title":"BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy","volume":"13","author":"Quinn","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2008.12.015","article-title":"BRCA1 and implications for response to chemotherapy in ovarian cancer","volume":"113","author":"Quinn","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"21","key":"10.1016\/j.path.2010.03.003_bib24","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.path.2010.03.003_bib25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.path.2010.03.003_bib27","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2010.03.003_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2010.03.003_bib29","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.path.2010.03.003_bib32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2010.03.003_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"25","key":"10.1016\/j.path.2010.03.003_bib34","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.path.2010.03.003_bib35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00000478-199411000-00006","article-title":"Pseudocarcinomatous hyperplasia of the fallopian tube associated with salpingitis. A report of 14 cases","volume":"18","author":"Cheung","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2010.03.003_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004347-200004000-00007","article-title":"Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment","volume":"19","author":"Yanai-Inbar","year":"2000","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.path.2010.03.003_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/PAS.0b013e31817d74a7","article-title":"Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2010.03.003_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10689-005-1838-3","article-title":"Gynecologic cancers in Lynch syndrome\/HNPCC","volume":"4","author":"Lu","year":"2005","journal-title":"Fam Cancer"},{"issue":"2","key":"10.1016\/j.path.2010.03.003_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.path.2010.03.003_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004347-199207000-00003","article-title":"Hereditary ovarian cancer: a clinicopathological study","volume":"11","author":"Bewtra","year":"1992","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"10.1016\/j.path.2010.03.003_bib41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31816380c4","article-title":"Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger","volume":"32","author":"Jensen","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2010.03.003_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"36","key":"10.1016\/j.path.2010.03.003_bib43","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1200\/JCO.2005.03.5915","article-title":"Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?","volume":"23","author":"Soliman","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.path.2010.03.003_bib44","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/PAS.0b013e3181bc9866","article-title":"Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2010.03.003_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10689-005-6573-2","article-title":"Survival of patients with ovarian cancer due to a mismatch repair defect","volume":"4","author":"Crijnen","year":"2005","journal-title":"Fam Cancer"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918110000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918110000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T16:22:48Z","timestamp":1543940568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918110000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1875918110000048"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2010.03.003","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}